No profile data available.
Lisata Therapeutics, Inc. (LSTA) is a healthcare company in the additional cancer treatment drugs industry, based in Basking Ridge, United States, with about 21 full-time employees.
It reported revenue of $170,000 for fiscal year 2025, down 83.0% from fiscal year 2024, and net income of -$16.59 million. In Q1 2026 (the quarter ended March 31, 2026) revenue was $0. Its market capitalization was $11.45 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Lisata Therapeutics reported $170,000 in revenue for fiscal year 2025, down 83.0% from $1.00 million in fiscal year 2024. In Q1 2026 revenue was $0.
$11.45 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Tempest Therapeutics, Inc. (TPST), Lantern Pharma Inc. (LTRN), Intensity Therapeutics, Inc. (INTS), Phio Pharmaceuticals Corp. (PHIO).